AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
Log in

NASDAQ:CGIXCancer Genetics SEC Filings & 10K Form

$2.92
-0.14 (-4.58 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.87
Now: $2.92
$3.04
50-Day Range
$2.73
MA: $3.04
$3.29
52-Week Range
$1.92
Now: $2.92
$9.50
Volume22,400 shs
Average Volume56,595 shs
Market Capitalization$6.13 million
P/E RatioN/A
Dividend YieldN/A
Beta2.1

SEC Filings

Cancer Genetics (NASDAQ:CGIX) SEC Filings

DateFilerForm TypeView
05/29/2020
4:17 PM
Cancer Genetics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2020
7:30 AM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2020
8:00 AM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2019
7:00 AM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2019
4:29 PM
Cancer Genetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2019
3:10 PM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2019
7:00 AM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2019
4:29 PM
Cancer Genetics (Issuer)
PRENDERGAST FRANKLYN G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2019
7:41 AM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2019
4:26 PM
Cancer Genetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/19/2019
3:18 PM
Cancer Genetics (Issuer)
Harris Geoffrey E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
3:15 PM
Cancer Genetics (Issuer)
Chaganti Raju S.K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
3:12 PM
Cancer Genetics (Issuer)
Cannon Edmund (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
3:09 PM
Cancer Genetics (Issuer)
McLeod Howard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2019
3:05 PM
Cancer Genetics (Filer)
Form NT 10-Q
08/13/2019
3:05 PM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2019
7:00 AM
Cancer Genetics (Filer)
Form 8-K/A
07/19/2019
4:30 PM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2019
4:23 PM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2019
4:17 PM
Cancer Genetics (Filer)
Form 8-K/A
07/09/2019
4:15 PM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2019
4:28 PM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2019
3:15 PM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2019
7:00 AM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2019
4:23 PM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2019
4:02 PM
Cancer Genetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/16/2019
5:08 AM
Cancer Genetics (Filer)
Form NT 10-Q
05/09/2019
8:00 AM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2019
4:15 PM
Cancer Genetics (Filer)
Form DEF 14A
04/29/2019
3:39 PM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2019
3:47 PM
Cancer Genetics (Filer)
Form PRE 14A
04/16/2019
6:19 AM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2019
8:57 PM
Cancer Genetics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/08/2019
3:05 PM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2019
3:54 PM
Cancer Genetics (Filer)
Form NT 10-K
02/15/2019
4:09 PM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2019
2:17 PM
Cancer Genetics (Subject)
PERKINS CAPITAL MANAGEMENT INC (Filed by)
Form SC 13G/A
02/13/2019
3:19 PM
Cancer Genetics (Subject)
Stonepine Capital Management, LLC (Filed by)
Form SC 13G/A
02/01/2019
3:05 PM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/01/2019
3:02 PM
Cancer Genetics (Issuer)
ROBERTS JOHN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2019
3:01 PM
Cancer Genetics (Issuer)
Miles Michael Glenn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2019
3:01 PM
Cancer Genetics (Issuer)
Cannon Edmund (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2019
3:00 PM
Cancer Genetics (Issuer)
PAPPAJOHN JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
4:25 PM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2019
4:24 PM
Cancer Genetics (Filer)
Form 424B5
01/28/2019
3:01 PM
Cancer Genetics (Filer)
Form 424B5
01/16/2019
4:03 PM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2019
3:47 PM
Cancer Genetics (Issuer)
Harris Geoffrey E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2019
3:45 PM
Cancer Genetics (Issuer)
PAPPAJOHN JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2019
3:42 PM
Cancer Genetics (Issuer)
ROBERTS JOHN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2019
7:56 AM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2019
3:10 PM
Cancer Genetics (Issuer)
Finger William Lansing (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/10/2019
4:04 PM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2019
4:01 PM
Cancer Genetics (Filer)
Form 424B5
01/10/2019
11:19 AM
Cancer Genetics (Subject)
SABBY MANAGEMENT, LLC (Filed by)
Form SC 13G
01/09/2019
3:02 PM
Cancer Genetics (Filer)
Form 424B5
01/09/2019
8:12 AM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2019
3:05 PM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2018
7:31 AM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2018
5:11 PM
Cancer Genetics (Issuer)
Miles Michael Glenn (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/21/2018
3:13 PM
Cancer Genetics (Subject)
Form 425
11/21/2018
3:10 PM
Cancer Genetics (Filer)
Form 8-K/A
11/19/2018
3:59 PM
Cancer Genetics (Subject)
Form 425
11/19/2018
3:56 PM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2018
3:05 PM
Cancer Genetics (Subject)
Form 425
11/16/2018
3:05 PM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2018
3:46 PM
Cancer Genetics (Subject)
Form 425
10/18/2018
3:05 PM
Cancer Genetics (Subject)
Form 425
10/16/2018
3:05 PM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2018
3:05 PM
Cancer Genetics (Subject)
Form 425
10/09/2018
7:48 AM
Cancer Genetics (Subject)
Form 425
10/09/2018
7:47 AM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/21/2018
3:06 PM
Cancer Genetics (Subject)
Form 425
09/21/2018
3:05 PM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2018
3:05 PM
Cancer Genetics (Issuer)
McCartney Michael Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2018
6:30 AM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2018
3:29 PM
Cancer Genetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2018
6:35 AM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2018
3:05 PM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2018
3:05 PM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/27/2018
3:44 PM
Cancer Genetics (Subject)
Iliad Research & Trading, L.P. (Filed by)
Form SC 13G
07/18/2018
3:18 PM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2018
3:59 PM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2018
3:05 PM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2018
3:39 PM
Cancer Genetics (Issuer)
McCartney Michael Brian (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/13/2018
3:55 PM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2018
6:05 AM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2018
3:19 PM
Cancer Genetics (Issuer)
Shaknovich Rita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2018
3:13 PM
Brandt Ralf (Reporting)
Cancer Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2018
7:45 AM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2018
7:31 AM
Cancer Genetics (Filer)
Form 10-K/A
04/27/2018
8:26 AM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2018
4:25 PM
Cancer Genetics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/02/2018
4:13 PM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2018
7:22 AM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/26/2018
2:29 PM
Cancer Genetics (Subject)
PERKINS CAPITAL MANAGEMENT INC (Filed by)
Form SC 13G/A
12/28/2017
7:03 AM
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2017
7:03 AM
Cancer Genetics (Filer)
Cancer Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/21/2017
4:20 PM
Cancer Genetics (Subject)
Stonepine Capital Management, LLC (Filed by)
Form SC 13G
12/18/2017
7:19 AM
Cancer Genetics (Issuer)
ROBERTS JOHN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 5/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.